Cardiac effects of drugs used for induction of labour and prevention and treatment of postpartum haemorrhage

Pregnancy presents significant stresses to a woman's body from the physiological changes to the cardiovascular system, fluid shifts at the time of delivery and the risk of major haemorrhage in the peri-partum period. Medications used routinely in daily obstetric practice may have potent vasoact...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cardiology congenital heart disease Vol. 5; p. 100208
Main Authors Lee, Sindy, Cauldwell, Matthew, Wendler, Renate
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.10.2021
Elsevier
Subjects
Cardiac disease
Cardiovascular
Induction
Labour
Major obstetric haemorrhage
Oxytocin
Post-partum haemorrhage
Labour
Post-partum haemorrhage
Oxytocin
Induction
Cardiac disease
Major obstetric haemorrhage
Online AccessGet full text

Cover

More Information
Summary:Pregnancy presents significant stresses to a woman's body from the physiological changes to the cardiovascular system, fluid shifts at the time of delivery and the risk of major haemorrhage in the peri-partum period. Medications used routinely in daily obstetric practice may have potent vasoactive effects. While most parturients are considered to be healthy and can withstand these significant physiological challenges, as the prevalence of cardiac disease among pregnant women increases it is important to consider the additional impact these medications may have in order to minimise the risk of cardiovascular instability and decompensation. This article will review drugs used in the induction of labour and the management of post-partum haemorrhage, and their relevance for women with cardiac disease.
ISSN:2666-6685
2666-6685
DOI:10.1016/j.ijcchd.2021.100208